Cervicitis by Iontophoresis

October 6 University

Status and phase: Not yet enrolling; Early Phase 1

Conditions: CERVICITIS

Treatments: Device: IONTOPHORESIS; Drug: ORAL ANTIBIOTIC

Study type: Interventional

Funder types: Other

Identifiers

NCT05675293

IONTOPHORESIS FOR CERVICITIS

Details and patient eligibility

About

The purpose of the study is to:

Investigate effect of iontophoresis on managing uterine cervicitis.

Enrollment: 40 estimated patients

Sex: Female

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. All patients have vaginal discharge.
2. All patients have irregular vaginal bleeding, especially after sexual intercourse.
3. All patients have dyspareunia.
4. All patients have Lower abdominal pain.
5. Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.
6. Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.

Exclusion criteria

1. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).
2. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.
3. In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.
4. It either should not be used or used with extreme caution during pregnancy.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

EXPERIMENTAL ARM

Experimental group

Treatment:

Device: IONTOPHORESIS

CONTROL ARM

Active Comparator group

Treatment:

Drug: ORAL ANTIBIOTIC